A 20-year-old economics student, Jeisson Pinzón, died on March 14 after months of battling leukemia and waiting for a critical medication, Blinatumomad, that Nueva EPS never supplied in time. Both opposition and government-aligned narratives, where they reference the case, agree that his family began formally requesting the drug in late 2023, that there were repeated administrative delays, and that the EPS only authorized the treatment after his death. Coverage converges on certain core facts: he needed the drug as a prerequisite for a bone marrow transplant, his plea for help went viral on social networks, judicial orders and formal petitions were issued, and despite all this, the medication did not arrive before his condition deteriorated irreversibly.

There is also shared acknowledgment that the case is emblematic of broader failures in Colombia’s health system, including bureaucratic barriers, delayed authorizations, and difficulties in accessing high-cost oncology and immunotherapy drugs. Both sides reference Nueva EPS as a large insurer under the current system, describe the repeated legal and administrative steps families must take to obtain treatments, and situate this case within a pattern of similar complaints from other patients such as those with chronic and catastrophic illnesses. Coverage generally concurs that the delays are not merely isolated mistakes but connected to structural problems in how services are authorized, supplied, and overseen, which has triggered renewed debate over health-sector oversight, patient protections, and the pace and scope of any reforms.

Areas of disagreement

Responsibility and blame. Opposition-aligned outlets typically frame Jeisson Pinzón’s death as the direct consequence of a collapsing health insurance model and place primary blame on the sitting government for failing to intervene decisively in Nueva EPS and the broader system. Government-aligned coverage, while critical of Nueva EPS, tends to emphasize the insurer’s specific negligence and the inherited systemic flaws of the EPS model rather than pinning the outcome squarely on the current administration. Opposition voices often personalize blame toward current officials, arguing that public warnings and viral testimonies were ignored, whereas government-aligned sources stress institutional inertia and corporate irresponsibility accumulated over years.

Systemic diagnosis. Opposition reporting commonly portrays the episode as proof that the entire managed-care framework is beyond repair and that government efforts to reform have been either cosmetic or misdirected. Government-aligned coverage, by contrast, uses the same facts to argue that the tragedy confirms long-standing critiques of private-intermediary EPSs and justifies structural reforms proposed or backed by the administration. While opposition media highlight chaos, underfunding, and alleged politicization of health management under the current government, pro-government outlets underscore regulatory gaps and profit-driven denial of care as legacies of earlier policies.

Reform and solutions. Opposition sources tend to warn that the government’s reform agenda could worsen access problems, claiming that centralization or abrupt institutional changes may generate more delays like those that affected Pinzón. Government-aligned outlets usually present the case as a rallying point for deep reform, arguing that only stronger public control, stricter oversight, or replacement of the EPS model can prevent similar deaths. Opposition narratives often foreground immediate sanctions or even liquidation of specific entities like Nueva EPS, while pro-government narratives frame the tragedy as evidence that broader systemic reengineering, not just punitive measures, is required.

Political framing and symbolism. Opposition media frequently depict Pinzón’s viral plea and subsequent death as an indictment of a government that, in their view, focuses on discourse rather than concrete problem-solving, reading the case as a symbol of broken campaign promises on health. Government-aligned coverage, conversely, tends to present him as a symbol of decades-long patient struggle against an entrenched EPS system and uses his story to bolster the moral urgency of the government’s legislative and regulatory agenda. The opposition often stresses public outrage against current authorities, while government-aligned narratives stress citizen mobilization in favor of reform and stronger state guarantees.

In summary, opposition coverage tends to emphasize current-government culpability and portray the case as evidence of mismanagement and looming systemic collapse, while government-aligned coverage tends to spotlight Nueva EPS and the inherited EPS model as the core problem and frame the tragedy as justification for the administration’s health reforms.